Esperion Therapeutics, Inc. (ESPR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.11 | +60.7% |
| 2024 | $-0.28 | +86.2% |
| 2023 | $-2.03 | +42.3% |
| 2022 | $-3.52 | +62.2% |
| 2021 | $-9.31 | -78.0% |
| 2020 | $-5.23 | -45.7% |
| 2019 | $-3.59 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.11 | +60.7% |
| 2024 | $-0.28 | +86.2% |
| 2023 | $-2.03 | +42.3% |
| 2022 | $-3.52 | +62.2% |
| 2021 | $-9.31 | -78.0% |
| 2020 | $-5.23 | -45.7% |
| 2019 | $-3.59 | — |